Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mayr

Showing results (421-430 of 451) with videos related to

Pageof 46
Sort By:
Tissue Antigens|March 1, 1997
Nomenclature for factors of the HLA system, 1996J G Bodmer, S G Marsh, E D Albert, et al.
Actas Urologicas Espanolas|February 15, 2025
Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic diseaseR Pichler, N C H van Creij, J D Subiela, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 26, 2001
Nomenclature for factors of the HLA system, 2000S G Marsh, J G Bodmer, E D Albert, et al.
Human Immunology|April 11, 2001
Nomenclature for factors of the HLA system, 2000S G Marsh, J G Bodmer, E D Albert, et al.
Vox Sanguinis|November 5, 1999
Nomenclature for factors of the HLA system, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Tissue Antigens|April 4, 2001
Nomenclature for factors of the HLA system, 2000S G Marsh, J G Bodmer, E D Albert, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|May 20, 1999
Nomenclature for factors of the HLA system, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Molecular Cancer|July 22, 2025
Primary and secondary metastatic dissemination: multiple routes to cancer-related deathD Sparrer, R Blazquez, F Keil, et al.
Human Immunology|June 11, 1999
Nomenclature for factors of the HLA System, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Tissue Antigens|May 13, 1999
Nomenclature for factors of the HLA system, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Pageof 46

Showing results (421-430 of 451) with videos related to

Sort By:
Pageof 46
Tissue Antigens|March 1, 1997
Nomenclature for factors of the HLA system, 1996J G Bodmer, S G Marsh, E D Albert, et al.
Actas Urologicas Espanolas|February 15, 2025
Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic diseaseR Pichler, N C H van Creij, J D Subiela, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 26, 2001
Nomenclature for factors of the HLA system, 2000S G Marsh, J G Bodmer, E D Albert, et al.
Human Immunology|April 11, 2001
Nomenclature for factors of the HLA system, 2000S G Marsh, J G Bodmer, E D Albert, et al.
Vox Sanguinis|November 5, 1999
Nomenclature for factors of the HLA system, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Tissue Antigens|April 4, 2001
Nomenclature for factors of the HLA system, 2000S G Marsh, J G Bodmer, E D Albert, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|May 20, 1999
Nomenclature for factors of the HLA system, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Molecular Cancer|July 22, 2025
Primary and secondary metastatic dissemination: multiple routes to cancer-related deathD Sparrer, R Blazquez, F Keil, et al.
Human Immunology|June 11, 1999
Nomenclature for factors of the HLA System, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Tissue Antigens|May 13, 1999
Nomenclature for factors of the HLA system, 1998J G Bodmer, S G Marsh, E D Albert, et al.
Pageof 46